AC Immune Advances ACI-24 Alzheimer’s Trial Expansion
LAUSANNE, Switzerland, April 2026 AC Immune SA announced continued progress in its Phase 1b/2 ABATE clinical trial evaluating ACI-24,...
Takeda
Advertisement
Anumana Secures FDA Clearance for AI ECG Detection Tool
CAMBRIDGE, Mass., March 28, 2026 Anumana, an AI-driven cardiovascular health technology company, announced that the U.S. Food and Drug...
Takeda Zasocitinib Shows Strong Phase 3 Psoriasis Data
OSAKA, Japan and CAMBRIDGE, Mass., March 28, 2026 Takeda announced positive results from its Phase 3 LATITUDE clinical trials...
Takeda Rolls Out Ready-to-Use Low-IgA Immunoglobulin Therapy
CAMBRIDGE, Massachusetts, January 22, 2026 — Takeda Pharmaceutical Company Limited announced the U.S. availability of GAMMAGARD LIQUID ERC, the...
Advertisement
